Our previous report has shown an association of CD38+ tumor-infiltrating leukocytes (TIL) with HCC prognosis and identified CD3+ T cells and monocytes as the dominant CD38-expressing immune populations among the TILs (14). The gene discussed is CD38; the disease is neoplasm.